Clinical Trial Update: Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing continuing alendronate versus taking a drug holiday to assess fracture risk in osteoporotic patients on long-term bisphosphonate therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Evangelisches Krankenhaus Lutherhaus gGmbH | Conditions: Osteoporosis | Phase 3 | Status: TERMINATED | Results posted: 2019-01-17